Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing the pharmaceutical industry-health system interface.

B J Zarowitz, B Muma, P Coggan

    The Annals of Pharmacotherapy
    |January 17, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.

    ESMO open·2026
    Same author

    The P4 study: Subsequent pregnancy maternal physiology after hypertensive and normotensive pregnancies.

    Pregnancy hypertension·2021
    Same author

    Clinico-radiological findings of neuroendocrine tumour metastases to the orbit.

    Orbit (Amsterdam, Netherlands)·2021
    Same author

    From commodity to money: The rise of silver coinage around the Ancient Mediterranean (sixth-first centuries bce).

    Archaeometry·2021
    Same author

    Dementia: is it time for targeted national screening?

    Journal of public health (Oxford, England)·2018
    Same author

    Unconscious priming dissociates 'free choice' from 'spontaneous urge' responses.

    Consciousness and cognition·2018

    Pharmaceutical marketing influences drug sales. A health system

    Area of Science:

    • Pharmaceutical marketing strategies
    • Healthcare system vendor policies
    • Drug detailing and sampling

    Background:

    • Pharmaceutical industry employs diverse marketing tactics to expand market share.
    • A health system implemented a strict vendor policy but required further analysis of pharmaceutical representative influence.

    Discussion:

    • Assessment of tangible benefits, ethical concerns, and financial implications of vendor interactions.
    • Re-evaluation of the necessity for enhanced vendor restrictions within the healthcare system.

    Key Insights:

    • Vendor policies are crucial for managing pharmaceutical influence.
    • Balancing drug promotion with patient welfare and ethical considerations is essential.
    • Financial and ethical analyses inform vendor policy adjustments.

    Related Experiment Videos

    Outlook:

    • Recommendations for medical practices and health systems regarding vendor policies.
    • Strategies for monitoring continuing medical education funding and ensuring appropriate drug utilization.
    • Proactive partnerships with pharmaceutical representatives to align detailing messages with system initiatives.